Login / Signup

Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma.

Nadine Abi-JaoudehFarshid DayyaniPei Jer ChenDayantha M FernandoNicholas FidelmanHanna JavanPo-Chin LiangJen-I Hwang
Published in: Journal of hepatocellular carcinoma (2021)
TAE with TPZ was safe and tolerable with encouraging results justifying pursuit of a Phase II trial.
Keyphrases
  • phase iii
  • open label
  • study protocol
  • phase ii
  • locally advanced
  • clinical trial
  • endothelial cells
  • liver metastases
  • placebo controlled
  • randomized controlled trial
  • squamous cell carcinoma
  • radiation therapy